BRPI0714755B8 - substituto salivar e receptáculo para substituto salivar - Google Patents

substituto salivar e receptáculo para substituto salivar

Info

Publication number
BRPI0714755B8
BRPI0714755B8 BRPI0714755A BRPI0714755A BRPI0714755B8 BR PI0714755 B8 BRPI0714755 B8 BR PI0714755B8 BR PI0714755 A BRPI0714755 A BR PI0714755A BR PI0714755 A BRPI0714755 A BR PI0714755A BR PI0714755 B8 BRPI0714755 B8 BR PI0714755B8
Authority
BR
Brazil
Prior art keywords
substitute
salivary
salivary substitute
receptacle
saliva
Prior art date
Application number
BRPI0714755A
Other languages
English (en)
Inventor
Deymes Jean
Perovitch Philippe
Original Assignee
Unither Dev
Unither Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unither Dev, Unither Pharmaceuticals filed Critical Unither Dev
Publication of BRPI0714755A2 publication Critical patent/BRPI0714755A2/pt
Publication of BRPI0714755B1 publication Critical patent/BRPI0714755B1/pt
Publication of BRPI0714755B8 publication Critical patent/BRPI0714755B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

substituto salivar, uso de substituto salivar e receptáculo para substituto salivar. o objeto da invenção é um substituto salivar realizado a partir de clara de ovo, de maneira a apresentar propriedades químicas, reológicas e fisiológicas análogas às da saliva humana natural. a invenção também se refere a seus usos e seu acondicionamento.
BRPI0714755A 2006-09-01 2007-08-28 substituto salivar e receptáculo para substituto salivar BRPI0714755B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0653549 2006-09-01
FR0653549A FR2905268B1 (fr) 2006-09-01 2006-09-01 Substitut salivaire
PCT/FR2007/051850 WO2008025926A2 (fr) 2006-09-01 2007-08-28 Substitut salivaire

Publications (3)

Publication Number Publication Date
BRPI0714755A2 BRPI0714755A2 (pt) 2013-05-14
BRPI0714755B1 BRPI0714755B1 (pt) 2019-10-01
BRPI0714755B8 true BRPI0714755B8 (pt) 2021-07-27

Family

ID=37873194

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0714755A BRPI0714755B8 (pt) 2006-09-01 2007-08-28 substituto salivar e receptáculo para substituto salivar

Country Status (12)

Country Link
US (1) US8216616B2 (pt)
EP (1) EP2056846B1 (pt)
JP (1) JP2010501640A (pt)
CN (1) CN101553239A (pt)
AU (1) AU2007291133B2 (pt)
BR (1) BRPI0714755B8 (pt)
CA (1) CA2661694C (pt)
ES (1) ES2424657T3 (pt)
FR (1) FR2905268B1 (pt)
PL (1) PL2056846T3 (pt)
RU (1) RU2472515C2 (pt)
WO (1) WO2008025926A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2116139A1 (en) * 2008-05-08 2009-11-11 Nestec S.A. Sialic acid to support brain health in the elderly
EP2116140A1 (en) * 2008-05-08 2009-11-11 Nestec S.A. Sialic acid to support the immune system in the elderly
EP2377526A1 (en) 2010-03-23 2011-10-19 BioAlliance Pharma Fast dissolving drug delivery systems
CA2794042A1 (en) 2010-03-23 2011-09-29 Bioalliance Pharma Fast dissolving drug delivery systems
US20110237563A1 (en) * 2010-03-23 2011-09-29 Dominique Costantini Fast dissolving drug delivery systems
KR101304766B1 (ko) * 2011-01-05 2013-09-05 서울대학교산학협력단 히알루론산을 포함하는 인공타액
KR101498510B1 (ko) * 2012-06-26 2015-03-04 서울대학교산학협력단 히알루론산을 포함하는 인공 타액 조성물
CN111012901B (zh) * 2020-01-10 2021-11-16 华中农业大学 一种含有卵粘蛋白和溶菌酶的人工唾液及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2590550B1 (fr) * 1985-11-26 1988-01-15 Atochem Recipients composites metalloplastiques assembles par soudure et leur procede de fabrication
US5541165A (en) * 1994-09-27 1996-07-30 Turgeon; Jean A. Saliva substitute
US5860806A (en) * 1996-11-29 1999-01-19 The Kerr Corporation Single dose dental adhesive delivery system and method and adhesive therefor
IE970541A1 (en) * 1997-07-25 1999-01-27 Michael Anthony Folan Maternal immune secretions and their use in the treatment and/or prophylaxis of the buccal cavity
RU2139069C1 (ru) * 1998-10-07 1999-10-10 Лях Светлана Павловна Средство для лечения патологических состояний "астромеланин"/"астронэлла")
US6773912B1 (en) * 1999-10-12 2004-08-10 University Of Otago Lantibiotic
EP1496851A1 (de) * 2002-04-25 2005-01-19 Gaba International AG Mundpflegemittel enthaltend ovomucin
RU2362552C1 (ru) * 2008-05-26 2009-07-27 Государственное образовательное учреждение высшего профессионального образования "Уральская государственная медицинская академия" Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО УГМА Росздрава) Препарат для заместительной терапии при сухости в полости рта

Also Published As

Publication number Publication date
BRPI0714755B1 (pt) 2019-10-01
FR2905268A1 (fr) 2008-03-07
JP2010501640A (ja) 2010-01-21
AU2007291133B2 (en) 2013-03-21
CA2661694A1 (fr) 2008-03-06
EP2056846A2 (fr) 2009-05-13
CA2661694C (fr) 2014-05-13
US20090317484A1 (en) 2009-12-24
ES2424657T3 (es) 2013-10-07
RU2009111875A (ru) 2010-10-10
AU2007291133A1 (en) 2008-03-06
WO2008025926A2 (fr) 2008-03-06
US8216616B2 (en) 2012-07-10
WO2008025926A3 (fr) 2008-04-17
BRPI0714755A2 (pt) 2013-05-14
CN101553239A (zh) 2009-10-07
RU2472515C2 (ru) 2013-01-20
PL2056846T3 (pl) 2013-10-31
EP2056846B1 (fr) 2013-07-03
FR2905268B1 (fr) 2009-01-23

Similar Documents

Publication Publication Date Title
BRPI0714755B8 (pt) substituto salivar e receptáculo para substituto salivar
CY1112623T1 (el) Χρηση πολυσακχαριδιων που περιεχουν λειτουργιες θειολης για αυξηση του ιστου
GB0818255D0 (en) Isolation and identification of glycosaminoglycans
ECSP13011139A (es) Anticuerpos contra la angiopoyetina 2 humana
ECSP12012211A (es) Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf)
BR112012013473A2 (pt) composição para higiene oral e método para o tratamento de uma doença ou condição do tecido mole da cavidade oral
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
WO2008130989A3 (en) Prosthetic implants
UY30513A1 (es) Composiciones de modificador de respuesta inmune y metodos
MX2009004623A (es) Imidazopiridazinas como inhibidores de la lipido cinasa pi3k.
BR112012013345A2 (pt) composições orais contendo uma combinação de extratos naturais e métodos relacionados
TR201901493T4 (tr) Diş temizleme ajanı.
IL185097A0 (en) Tissue specific expression of antibodies in chickens
NI201000189A (es) Formulación de medicamento sólido con liberación retardadas.
TR200806298A2 (tr) Farmasötik formülasyon
GR1006227B (el) Ενιαιο ενδοστικο οδοντικο εμφυτευμα τιτανιου ή ζιρκονιας σε συνδυασμο με κεραμικο ή υαλοκεραμικο διαβλενογονιο προσαρτημα
ATE507812T1 (de) Zahnzementsystem
CY1115734T1 (el) Συνθεσεις benzenesulfonamide, μεθοδος συνθεσης τους, και χρηση αυτων στην ιατρικη
CL2022003181A1 (es) Uso de oligosacáridos de la leche humana en composiciones nutricionales para mejorar el desarrollo óseo
BRPI0707420A8 (pt) composições contendo peptídeos com aminoácidos e métodos não naturais do uso
FR2968558B1 (fr) Composition a base d'extrait d'algues a usage bucco-dentaire
BR112012008838A2 (pt) composição de tratamento para papel de limpeza
TR201004464A2 (tr) Kemik erimesi için formülasyon.
AR086437A1 (es) Preparado de huevo con propiedades regeneradoras, analgesicas y/o anti-inflamatorias
UY30198A1 (es) Dominios kunitz quiméricos y su uso

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: UNITHER PHARMACEUTICALS (FR)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/10/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/08/2007, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2737 DE 20-06-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.